These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 194077

  • 1. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
    Adachi K, Numano F.
    Jpn J Pharmacol; 1977 Feb; 27(1):97-103. PubMed ID: 194077
    [Abstract] [Full Text] [Related]

  • 2. Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
    Prasad KN, Becker G, Tripathy K.
    Proc Soc Exp Biol Med; 1975 Jul; 149(3):757-62. PubMed ID: 167381
    [Abstract] [Full Text] [Related]

  • 3. Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
    Rusin LJ, Duell EA, Voorhees JJ.
    J Invest Dermatol; 1978 Aug; 71(2):154-6. PubMed ID: 210235
    [Abstract] [Full Text] [Related]

  • 4. Effect of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propranolol on adenylate cyclase and 3,5'-cyclic AMP phosphodiesterase in vitro.
    Yamashita Y, Kawai M, Hotta K.
    Jpn J Pharmacol; 1976 Jun; 26(3):391-4. PubMed ID: 185445
    [No Abstract] [Full Text] [Related]

  • 5. Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture.
    Prasad KN, Sakamoto A.
    Experientia; 1978 Dec 15; 34(12):1575-6. PubMed ID: 215447
    [Abstract] [Full Text] [Related]

  • 6. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
    Schwabe U, Miyake M, Ohga Y, Daly JW.
    Mol Pharmacol; 1976 Nov 15; 12(6):900-10. PubMed ID: 187926
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B, Ruckstuhl M, Landry Y.
    J Pharmacol; 1982 Nov 15; 13(2):307-16. PubMed ID: 6285085
    [Abstract] [Full Text] [Related]

  • 8. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H, Asano T.
    J Biol Chem; 1976 Dec 10; 251(23):7508-16. PubMed ID: 187590
    [Abstract] [Full Text] [Related]

  • 9. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF, Shoji M, Brackett NL, Helfman DM.
    J Cyclic Nucleotide Res; 1978 Dec 10; 4(6):463-74. PubMed ID: 85641
    [Abstract] [Full Text] [Related]

  • 10. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS, Rhoads AR.
    Biochem Pharmacol; 1982 Mar 01; 31(5):665-9. PubMed ID: 6177320
    [Abstract] [Full Text] [Related]

  • 11. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
    Goff AK, Major PW.
    FEBS Lett; 1976 Jan 15; 61(2):144-7. PubMed ID: 174943
    [No Abstract] [Full Text] [Related]

  • 12. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
    Némoz G, Prigent AF, Picq M, Pacheco H.
    Biochem Pharmacol; 1982 Nov 01; 31(21):3353-8. PubMed ID: 6293510
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
    Glass WF, Moore JB.
    Biochem Pharmacol; 1979 Apr 01; 28(7):1107-12. PubMed ID: 87197
    [No Abstract] [Full Text] [Related]

  • 14. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H, Asano T.
    Biochim Biophys Acta; 1976 Apr 08; 429(2):485-97. PubMed ID: 177073
    [Abstract] [Full Text] [Related]

  • 15. Cyclic AMP-phosphodiesterase and epidermal mitosis.
    Birnbaum JE, Sapp TM, Tolman EL.
    J Invest Dermatol; 1976 Aug 08; 67(2):235-9. PubMed ID: 181495
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
    Shimoyama M, Kawai M, Nasu S, Shioji K, Hoshi Y.
    Physiol Chem Phys; 1975 Aug 08; 7(2):125-32. PubMed ID: 239431
    [Abstract] [Full Text] [Related]

  • 17. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
    Manganiello V, Degerman E, Elks M.
    Methods Enzymol; 1988 Aug 08; 159():504-20. PubMed ID: 2457789
    [No Abstract] [Full Text] [Related]

  • 18. Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase.
    Lehnert S.
    Int J Radiat Oncol Biol Phys; 1979 Jun 08; 5(6):825-33. PubMed ID: 91600
    [No Abstract] [Full Text] [Related]

  • 19. Reticulol, an inhibitor of cyclic adenosine 3', 5'-monophosphate phosphodiesterase.
    Furutani Y, Shimada M, Hamada M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1975 Jul 08; 28(7):558-60. PubMed ID: 168174
    [No Abstract] [Full Text] [Related]

  • 20. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
    Miyamoto M, Takayanagi I, Ohkubo H, Takagi K.
    Jpn J Pharmacol; 1976 Feb 08; (1):114-7. PubMed ID: 177797
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.